Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

A commission of top United Nations human rights watchdogs sent a series of blistering letters to the heads of five U.S. universities raising sharp concerns over the treatment of pro-Palestine students ...

Brookmont Catastrophic Bond ETF offers retail investors exposure to catastrophe bonds, a previously inaccessible fixed income niche. ILS provides uncorrelated returns versus traditional corporate ...

Once again, Israeli bombs rained down on Gaza. The latest wave of strikes killed more than 100 people, mostly women and children, according to health authorities. The bombardment marked the deadliest ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

Three current Pentagon officials decried a new War Department policy designed to restrict press freedom. Under new rules, the Department of War said it would forbid reporters from gathering any ...

For years, Arizona Attorney General Kris Mayes defended the Transaction Record Analysis Center, a secretive financial surveillance program that tracks wire transfers between the U.S. and Mexico sent ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.